Cargando…

Combined Docetaxel/Pictilisib-Loaded mPEGylated Nanocarriers with Dual HER2 Targeting Antibodies for Synergistic Chemotherapy of Breast Cancer

INTRODUCTION: Approximately 15%~30% of breast cancers have gene amplification or overexpression of the human epidermal growth factor receptor 2 (HER2), resulting in the chemotherapy resistance, a more-aggressive phenotype and poor prognosis. METHODS: We propose a strategy of nanocarriers co-loaded w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Wei-Jie, Lin, Shyr-Yi, Chuang, Kuo-Hsiang, Chen, Michael, Ho, Hsiu-O, Chen, Ling-Chun, Hsieh, Chien-Ming, Sheu, Ming-Thau
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677924/ https://www.ncbi.nlm.nih.gov/pubmed/36419719 http://dx.doi.org/10.2147/IJN.S388066

Ejemplares similares

Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
por: Su, Chia-Yu, et al.
Publicado: (2018)

Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity
por: Cheng, Wei-Jie, et al.
Publicado: (2021)

Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy
por: Lin, Wen-Wei, et al.
Publicado: (2021)

Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
por: Chang, Chia-En, et al.
Publicado: (2018)

Functionalization of silver nanoparticles with mPEGylated luteolin for selective visual detection of Hg(2+) in water sample
por: Qing, Weixia, et al.
Publicado: (2018)

A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer
por: Khalafi, Shayan, et al.
Publicado: (2021)

Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer
por: Liu, Yu-Hsuan, et al.
Publicado: (2023)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
por: Li, Ke, et al.
Publicado: (2019)

Determination of total and unbound docetaxel in plasma by ultrafiltration and UPLC-MS/MS: application to pharmacokinetic studies
por: Sheu, Ming-Thau, et al.
Publicado: (2017)

Publisher Correction: Determination of total and unbound docetaxel in plasma by ultrafiltration and UPLC-MS/MS: application to pharmacokinetic studies
por: Sheu, Ming-Thau, et al.
Publicado: (2018)

A Novel Composite Hydrogel Composed of Formic Acid-Decellularized Pepsin-Soluble Extracellular Matrix Hydrogel and Sacchachitin Hydrogel as Wound Dressing to Synergistically Accelerate Diabetic Wound Healing
por: Hsieh, Chien-Ming, et al.
Publicado: (2020)

CPT11 with P-glycoprotein/CYP 3A4 dual-function inhibitor by self-nanoemulsifying nanoemulsion combined with gastroretentive technology to enhance the oral bioavailability and therapeutic efficacy against pancreatic adenocarcinomas
por: Chen, Ling-Chun, et al.
Publicado: (2021)

Characterizations of Plasticized Polymeric Film Coatings for Preparing Multiple-Unit Floating Drug Delivery Systems (muFDDSs) with Controlled-Release Characteristics
por: Hung, Sheng-Feng, et al.
Publicado: (2014)

Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas
por: Cheng, Wen-Ting, et al.
Publicado: (2021)

Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer
por: Cheng, Yi-An, et al.
Publicado: (2020)

Lecithin-Stabilized Polymeric Micelles (L(sb)PMs) for Delivering Quercetin: Pharmacokinetic Studies and Therapeutic Effects of Quercetin Alone and in Combination with Doxorubicin
por: Chang, Chia-En, et al.
Publicado: (2018)

The influence of nanocarrier architectures on antitumor efficacy of docetaxel nanoparticles
por: Dong, Zhengqi, et al.
Publicado: (2020)

PEGylated ethyl cellulose micelles as a nanocarrier for drug delivery
por: Singam, Amarnath, et al.
Publicado: (2021)

Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers
por: Muralidharan, Priya, et al.
Publicado: (2014)

Inhibition of Phosphatidylinositol 3-Kinase by Pictilisib Blocks Influenza Virus Propagation in Cells and in Lungs of Infected Mice
por: Deinhardt-Emmer, Stefanie, et al.
Publicado: (2021)

Multifunctional PEGylated Niosomal Nanoparticle-Loaded Herbal Drugs as a Novel Nano-Radiosensitizer and Stimuli-Sensitive Nanocarrier for Synergistic Cancer Therapy
por: Afereydoon, Saeid, et al.
Publicado: (2022)

Development and characterization of a gastroretentive dosage form composed of chitosan and hydroxyethyl cellulose for alendronate
por: Chen, Ying-Chen, et al.
Publicado: (2013)

On-demand PEGylation and dePEGylation of PLA-based nanocarriers via amphiphilic mPEG-TK-Ce6 for nanoenabled cancer chemotherapy
por: Zhu, Yueqiang, et al.
Publicado: (2019)

Pegylated Liposomal Doxorubicin, Docetaxel, and Trastuzumab as Neoadjuvant Treatment for HER2-Positive Breast Cancer Patients: A Phase II and Biomarker Study
por: Wang, Haoqi, et al.
Publicado: (2022)

Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview
por: A. Razak, S. Aishah, et al.
Publicado: (2021)

Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles
por: Hsieh, Yuan-Chin, et al.
Publicado: (2016)

TGF-β inhibits IL-1β-activated PAR-2 expression through multiple pathways in human primary synovial cells
por: Tsai, Shin-Han, et al.
Publicado: (2009)

Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment
por: Varan, Cem, et al.
Publicado: (2017)

Functionalized Lipid Nanocarriers for Simultaneous Delivery of Docetaxel and Tariquidar to Chemoresistant Cancer Cells
por: Kim, Chang Hyun, et al.
Publicado: (2023)

Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles
por: Chen, Ying-Chen, et al.
Publicado: (2015)

Swelling/Floating Capability and Drug Release Characterizations of Gastroretentive Drug Delivery System Based on a Combination of Hydroxyethyl Cellulose and Sodium Carboxymethyl Cellulose
por: Chen, Ying-Chen, et al.
Publicado: (2015)

Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel
por: Odeh, Fadwa, et al.
Publicado: (2019)

Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs
por: Wang, Chunling, et al.
Publicado: (2015)

PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity
por: Pei, Xibo, et al.
Publicado: (2020)

Combining “Bottom‐up” and “Top‐down” Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC‐0941) Pharmacokinetics
por: Lu, Tong, et al.
Publicado: (2017)

A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer
por: Schöffski, Patrick, et al.
Publicado: (2018)

Pictilisib Enhances the Antitumor Effect of Doxorubicin and Prevents Tumor-Mediated Bone Destruction by Blockade of PI3K/AKT Pathway
por: Liang, Chao, et al.
Publicado: (2021)

Pictilisib-Induced Resistance Is Mediated through FOXO1-Dependent Activation of Receptor Tyrosine Kinases in Mucinous Colorectal Adenocarcinoma Cells
por: Kuracha, Murali R., et al.
Publicado: (2023)

Poloxamer sols endowed with in-situ gelability and mucoadhesion by adding hypromellose and hyaluronan for prolonging corneal retention and drug delivery
por: Chen, Ling-Chun, et al.
Publicado: (2023)

Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy
por: Cheng, Wei-Jie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_65m5ejo87v0e628ogv1cmmgs14